10.31.24 -- When Should You Select Your Supply Partner?

Now available on demand! Choosing the right CDMO for antibody development is crucial. The wrong partner can lead to delays and quality issues, while the right one can streamline development and improve commercialization success. Join Outsourced Pharma's expert panel on CDMO selection for biologic drug developers, where experts will discuss qualification processes, partnership management, team and facility compatibility, and how to leverage your CDMO's strategic expertise.

The regulatory affairs function is no longer a "one size fits all" function, the decision to outsource or insource the function is growing more complex, and specific AI tools can help regulatory processes.

Review key methods which are applied to ensure safety of such recombinant proteins, with a focus on alternate and superior methods to the standard transmission electron microscopy (TEM) method.

Project managers (PMs) must be technically adept enough to understand a project, but their main role is to ensure it delivers in terms of scope and budget.

Examine how leveraging a fully robotic aseptic filling system enables versatility, high yields, and low losses, as well as precise and repeatable fill parameters batch to batch.

A partner experienced in development and manufacturing techniques, capable of guiding a nasal delivery program from small-scale clinical to commercial supply, is crucial.

Capacity constraints typically are accompanied by other challenges, including missed timelines, defect rates, and overall decreased satisfaction with pharma companies’ bioprocessing CDMOs.

See how AI is transforming the biomanufacturing industry and how partnerships between pharmaceutical companies and academic institutions are poised to set the new standard.

Learn how to navigate the wide range of "quality claims" and find a CDMO partner that is committed to a culture of quality, placing safety and product excellence at the core of their operations.

Consider these strategies to improve the performance of IB processes as well as the pros and cons of soluble and insoluble processes: isolating, solubilizing, and properly refolding.

With insight gained from producing more than 200 biologics to date, we have established downstream platforms that allow us to move quickly into a product’s manufacturing phase.

Leveraging robust analytical services at every stage of development and manufacturing is crucial to ensure your therapy reaches patients in need on time and within budget.

Discover how our specialized R&D and manufacturing services can support your product development needs at every stage by learning more about our cutting-edge solutions, here.

Explore our fill line capabilities, including vial and syringe handling. Schedule an immersive tour of our drug product filling facility in Denmark. Our experienced team is available to discuss your needs.